62
Participants
Start Date
September 30, 2019
Primary Completion Date
December 21, 2022
Study Completion Date
December 21, 2022
Marine polysaccharide dressing
The MPS-Ag dressing used in this study has a unique gelling action which helps to remove dead, damaged, and infected tissues from the wound by trapping and removing them later at dressing changes. It is designed to provide intimate contact with the wound for gentle healing. It also contains ionic silver.
Carboxymethylcellulose dressing
The CMC-Ag dressing used in this study incorporates two technologies to help eliminate the key barriers to healing that are exudate, infection, and bioburden. It can be used on chronic and acute wounds that are infected or at risk of infection with varying exudate levels.
Wake Forest Baptist Health, Winston-Salem
Covenant Hospital, Saginaw
Central Valley Vein and Wound Center, Selma
Valley Vascular Surgery Associates, Fresno
Boston Medical Center, Boston
Lead Sponsor
Medline Industries
INDUSTRY